1. Revised recommendations for reducing the risk of Zika virus transmission by blood and blood components Publication: Silver Spring, MD : Center for Biologics Evaluation and Research, July 2018 Subject(s): Blood Component TransfusionBlood Safety -- standardsBlood TransfusionZika Virus Infection -- bloodZika Virus Infection -- transmissionBlood DonorsZika Virus Infection -- epidemiologyHumansUnited StatesUnited States. Department of Health and Human Services.United States. Food and Drug Administration.
2. Nucleic acid testing (NAT) for human immunodeficiency virus type 1 (HIV-1) and hepatitis C virus (HCV): testing, product disposition, and donor deferral and reentry Publication: Silver Spring, MD : Center for Biologics Evaluation and Research, December 2017 Subject(s): Blood DonorsDonor Selection -- standardsHepacivirusHepatitis C -- bloodHIV Infections -- bloodHIV-1RNA, Viral -- bloodBlood -- virologyBlood TransfusionDisease Transmission, Infectious -- prevention & controlNucleic Acid Amplification TechniquesPolymerase Chain ReactionHumansUnited StatesUnited States. Department of Health and Human Services.United States. Food and Drug Administration.
3. Recommendations for reducing the risk of transfusion-transmitted babesiosis Publication: Silver Spring, MD : Center for Biologics Evaluation and Research, May 2019 Subject(s): Babesiosis -- transmissionBlood TransfusionDisease Transmission, Infectious -- prevention & controlDonor Selection -- standardsBabesiosis -- prevention & controlBlood -- microbiologySurveys and QuestionnairesHumansUnited StatesUnited States. Department of Health and Human Services.United States. Food and Drug Administration.
